Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1Phase 1 1

Status

Active not recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Prostatic Neoplasms 85Lung Neoplasms 63Carcinoma, Non-Small-Cell Lung 50Neoplasm Metastasis 48Breast Neoplasms 48Glioma 41Glioblastoma 38Pancreatic Neoplasms 35Multiple Myeloma 35Brain Neoplasms 34Carcinoma, Renal Cell 32Lymphoma, Large B-Cell, Diffuse 29Melanoma 28Urinary Bladder Neoplasms 27Colorectal Neoplasms 27Squamous Cell Carcinoma of Head and Neck 25Ovarian Neoplasms 24Triple Negative Breast Neoplasms 21Oropharyngeal Neoplasms 21Carcinoma, Hepatocellular 21Lymphoma 20Mouth Neoplasms 18Lymphoma, Follicular 18Sarcoma 17Fallopian Tube Neoplasms 16Carcinoma 16Laryngeal Neoplasms 15Carcinoma, Transitional Cell 15Astrocytoma 15Lymphoma, Mantle-Cell 14

Interventions

Magnetic Resonance Spectroscopy 3Blood Specimen Collection 3Specimen Handling 2Simvastatin 2Liver Transplantation 2tremelimumab 1sofosbuvir-velpatasvir drug combination 1epigallocatechin gallate 1durvalumab 1atezolizumab 1apixaban 1User-Centered Design 1Tocopherols 1Surveys and Questionnaires 1Standard of Care 1Sodium Chloride 1Sampling Studies 1Radiotherapy 1Radiation 1Pravastatin 1Phlebotomy 1Pharmaceutical Preparations 1Pentoxifylline 1Patient Navigation 1Neuropsychological Tests 1Musculoskeletal Manipulations 1Memantine 1Losartan 1Ketoprofen 1Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Fibrosis × Magnetic Resonance Spectroscopy × 1 year × Clear all
NCT02968810 2026-05-29

Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis

National Cancer Institute (NCI)

Phase 2 Active not recruiting
52 enrolled 15 charts
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

NCT02626312 2026-04-30

Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function

M.D. Anderson Cancer Center

Phase 1 Active not recruiting
36 enrolled
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Cholangiocarcinoma

NCT07042919 2025-06-29

Zanzalintinib in Second Line and Beyond for the Treatment of Advanced Liver Cancer

Northwestern University

Phase 1/2 Not yet recruiting
53 enrolled
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡